Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningLiver TransplantationStem Cell TransplantationMultiple MyelomaHematopoietic Stem CellsKidney TransplantationHematopoietic Stem Cell MobilizationAntigens, CD34MelphalanGraft SurvivalStem CellsPeripheral Blood Stem Cell TransplantationCell TransplantationTreatment OutcomeCombined Modality TherapyLymphoma, Non-HodgkinHeart TransplantationGranulocyte Colony-Stimulating FactorBone Marrow PurgingSalvage TherapyLeukapheresisLung TransplantationWhole-Body IrradiationCarmustineGraft vs Host DiseaseRecurrenceCell DifferentiationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsRemission InductionBone Marrow CellsHematopoiesisColony-Forming Units AssayCells, CulturedBone MarrowTime FactorsHematologic NeoplasmsDisease-Free SurvivalEtoposideBusulfanOrgan TransplantationSurvival AnalysisRetrospective StudiesHodgkin DiseaseBlood Transfusion, AutologousGraft RejectionImmunosuppressive AgentsSurvival RateCytarabineCell SeparationTissue DonorsTransplantation ChimeraIslets of Langerhans TransplantationTransplantation ImmunologyPancreas TransplantationTransplantationFollow-Up StudiesGraft vs Tumor EffectMyeloablative AgonistsFlow CytometryCell LineageKanamycin KinaseThalidomideTransplantation, IsogeneicBlood Component RemovalCell Culture TechniquesCord Blood Stem Cell TransplantationBlood Cell CountAntigens, CDFeasibility StudiesImmune Reconstitution Inflammatory SyndromeGenetic TherapyLeukemiaMyeloid Progenitor CellsVincristinePrognosisMice, Inbred C57BLLymphomaLeukemia, Myeloid, AcuteGenetic VectorsNeoplasm, ResidualTransduction, GeneticImmunomagnetic SeparationTransplantation, HeterotopicLiving DonorsIdarubicinPrednisoneMyelodysplastic SyndromesLentivirusAntineoplastic Agents, AlkylatingRecombinant ProteinsT-LymphocytesDexamethasoneAntibodies, MonoclonalHeart-Lung TransplantationFetal Tissue Transplantation